Literature DB >> 12070667

Consensus neuropathological diagnosis of common dementia syndromes: testing and standardising the use of multiple diagnostic criteria.

G Halliday1, T Ng, M Rodriguez, A Harding, P Blumbergs, W Evans, V Fabian, J Fryer, M Gonzales, C Harper, R Kalnins, C L Masters, C McLean, D G Milder, R Pamphlett, G Scott, A Tannenberg, J Kril.   

Abstract

The aim of this study was to assess the variation between neuropathologists in the diagnosis of common dementia syndromes when multiple published protocols are applied. Fourteen out of 18 Australian neuropathologists participated in diagnosing 20 cases (16 cases of dementia, 4 age-matched controls) using consensus diagnostic methods. Diagnostic criteria, clinical synopses and slides from multiple brain regions were sent to participants who were asked for case diagnoses. Diagnostic sensitivity, specificity, predictive value, accuracy and variability were determined using percentage agreement and kappa statistics. Using CERAD criteria, there was a high inter-rater agreement for cases with probable and definite Alzheimer's disease but low agreement for cases with possible Alzheimer's disease. Braak staging and the application of criteria for dementia with Lewy bodies also resulted in high inter-rater agreement. There was poor agreement for the diagnosis of frontotemporal dementia and for identifying small vessel disease. Participants rarely diagnosed more than one disease in any case. To improve efficiency when applying multiple diagnostic criteria, several simplifications were proposed and tested on 5 of the original 20 cases. Inter-rater reliability for the diagnosis of Alzheimer's disease and dementia with Lewy bodies significantly improved. Further development of simple and accurate methods to identify small vessel lesions and diagnose frontotemporal dementia is warranted.

Entities:  

Mesh:

Year:  2002        PMID: 12070667     DOI: 10.1007/s00401-002-0529-5

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  15 in total

1.  Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.

Authors:  Thomas G Beach; Sarah E Monsell; Leslie E Phillips; Walter Kukull
Journal:  J Neuropathol Exp Neurol       Date:  2012-04       Impact factor: 3.685

Review 2.  Neuropsychological differences between frontotemporal dementia and Alzheimer's disease: a review.

Authors:  Michal Harciarek; Krzysztof Jodzio
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

Review 3.  Proceedings from the Albert Charitable Trust Inaugural Workshop on white matter and cognition in aging.

Authors:  Farzaneh A Sorond; Shawn Whitehead; Ken Arai; Douglas Arnold; S Thomas Carmichael; Charles De Carli; Marco Duering; Myriam Fornage; Rafael E Flores-Obando; Jonathan Graff-Radford; Edith Hamel; David C Hess; Massafumi Ihara; Majken K Jensen; Hugh S Markus; Axel Montagne; Gary Rosenberg; Andy Y Shih; Eric E Smith; Alex Thiel; Kai Hei Tse; Donna Wilcock; Frank Barone
Journal:  Geroscience       Date:  2019-12-06       Impact factor: 7.713

4.  Thinking outside the box: Alzheimer-type neuropathology that does not map directly onto current consensus recommendations.

Authors:  Peter T Nelson; Walter A Kukull; Matthew P Frosch
Journal:  J Neuropathol Exp Neurol       Date:  2010-05       Impact factor: 3.685

5.  Applicability of digital analysis and imaging technology in neuropathology assessment.

Authors:  William D Dunn; Marla Gearing; Yuna Park; Lifan Zhang; John Hanfelt; Jonathan D Glass; David A Gutman
Journal:  Neuropathology       Date:  2015-11-18       Impact factor: 1.906

6.  The NSW brain tissue resource centre: Banking for alcohol and major neuropsychiatric disorders research.

Authors:  G T Sutherland; D Sheedy; J Stevens; T McCrossin; C C Smith; M van Roijen; J J Kril
Journal:  Alcohol       Date:  2016-03-14       Impact factor: 2.405

7.  Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity.

Authors:  Peter T Nelson; Gregory A Jicha; Frederick A Schmitt; Huaichen Liu; Daron G Davis; Marta S Mendiondo; Erin L Abner; William R Markesbery
Journal:  J Neuropathol Exp Neurol       Date:  2007-12       Impact factor: 3.685

8.  Theoretical impact of Florbetapir (18F) amyloid imaging on diagnosis of alzheimer dementia and detection of preclinical cortical amyloid.

Authors:  Thomas G Beach; Julie A Schneider; Lucia I Sue; Geidy Serrano; Brittany N Dugger; Sarah E Monsell; Walter Kukull
Journal:  J Neuropathol Exp Neurol       Date:  2014-10       Impact factor: 3.685

9.  Lipid pathway alterations in Parkinson's disease primary visual cortex.

Authors:  Danni Cheng; Andrew M Jenner; Guanghou Shui; Wei Fun Cheong; Todd W Mitchell; Jessica R Nealon; Woojin S Kim; Heather McCann; Markus R Wenk; Glenda M Halliday; Brett Garner
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

10.  Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study.

Authors:  Fiona E Matthews; Carol Brayne; James Lowe; Ian McKeith; Stephen B Wharton; Paul Ince
Journal:  PLoS Med       Date:  2009-11-10       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.